Quick Answer
Bone Biologics Corp reported Research And Development Expense of $1.06 million for the year ending 2025.
- Bone Biologics Corp showed a decrease of -50.2% in Research And Development Expense from 2024 to 2025.
- This data is from Bone Biologics Corp's annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $188.3 thousand | Q2 2015: $175.0 thousand | Q3 2015: $302.7 thousand | Q1 2016: $4.68 million | Q2 2016: $2.32 million | Q3 2016: $2.47 million | Q4 2016: $3.63 million | Q1 2017: $406.9 thousand | Q2 2017: $423.9 thousand | Q3 2017: $234.3 thousand | Q1 2018: $369.0 thousand | Q2 2018: $187.5 thousand | Q3 2018: -$1.07 million | Q1 2019: $564.3 thousand | Q2 2019: $417.6 thousand | Q3 2019: $44.9 thousand | Q1 2020: $167.1 thousand | Q2 2020: $9.0 thousand | Q3 2020: $142.9 thousand | Q1 2021: $45.5 thousand | Q2 2021: $2.0 thousand | Q1 2022: $36.4 thousand | Q2 2022: $17.6 thousand | Q3 2022: $769.4 thousand | Q1 2023: $2.59 million | Q2 2023: $2.30 million | Q3 2023: $1.57 million | Q1 2024: $245.6 thousand | Q2 2024: $350.4 thousand | Q3 2024: $429.7 thousand | Q1 2025: $423.6 thousand | Q2 2025: $191.6 thousand | Q3 2025: $187.8 thousand.
- Over the full 13 years of available data (2013 to 2025), Bone Biologics Corp's Research And Development Expense has grown by 463.2%.
- Historical annual values: Fiscal year 2025: $1.06 million | Fiscal year 2024: $2.13 million | Fiscal year 2023: $6.91 million | Fiscal year 2022: $1.58 million | Fiscal year 2021: $82.0 thousand | Fiscal year 2020: $340.7 thousand | Fiscal year 2019: $1.10 million | Fiscal year 2018: $104.5 thousand | Fiscal year 2017: $1.42 million | Fiscal year 2016: $10.17 million | Fiscal year 2015: $3.67 million | Fiscal year 2014: $623.5 thousand | Fiscal year 2013: $188.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: